Search for: "Dr. Reddy" Results 261 - 280 of 395
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Oct 2010, 8:56 pm by Kelly
Apotex asks Supreme Court to review generic Cozaar/Hyzaar 180-day exclusivity decision (FDA Law Blog) Faslodex (Fulvestrant) – US: AstraZeneca seeks review of BPAI decision concerning patent covering ‘Use of Fulvestrant in treatment of resistant breast cancer’ (Patent Docs) Gemzar (Gemcitabine) – US: Eli Lilly files patent infringement complaint against Dr Reddy’s following Para IV certification (Patent Docs) Lipitor (Atorvastatin) – US: Generic… [read post]
10 Oct 2010, 6:21 am
Also brought within the IPO’s corral is the decision in Dr Reddy’s Laboratories (UK) Ltd v Eli Lilly & Co Ltd [2010] RPC 8 (noted by the IPKat here), in which the Court of Appeal delved into the murky depths of selection invention – asking, in the process, where a wise man would hide a leaf… The sections on supplementary protection certificates has also been updated in light of the decisions of the High Court in Yeda Research and Development Company Ltd… [read post]
15 Sep 2010, 2:40 am by Kelly
(Afro-IP) Africa: Giving consumers power in the battle against counterfeits (Afro-IP) Australia: Review Four Corners’ ‘Body Corporate’ program on gene patenting (Patentology) India: Roche and Novartis, finally, manage to defend their patents in oppositions filed by Cipla (Spicy IP) South Africa: San people push for new legislation – demand protection for indigenous knowledge and IP including medicinal remedies derived from plants including Hoodia (Afro-IP) US: PHOSITA:… [read post]
20 Aug 2010, 1:41 pm by WIMS
(WIMS) Publishers of Michigan Waste Report, REGTrak, WIMS Daily & eNewsUSA Jeff Dauphin, President 767 Kornoelje Dr. [read post]
23 Jun 2010, 10:28 pm
Reddy's over generic Allegra (Patent Docs) Combigan (Brimonidine) – US: Patent infringement complaint following a Para IV certification: Allergan, Inc. v. [read post]
3 Jun 2010, 5:35 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/   Highlights this week included: US: Sen Kerry introduces Angiomax PTE amendment to Tax Extenders Act of 2009 (FDA Law Blog)   General Nature Biotechnology and more anti-gene patenting myths (Patent Docs) Alice de Pastor’s SPC news 2009 (The SPC Blog) US: Sen Kerry introduces Angiomax PTE amendment to Tax Extenders Act of 2009 (FDA Law Blog) US: Blinded… [read post]
26 May 2010, 4:00 pm by Heather Young
 PHS' hospitals provided more than $120 Million in charity care to the uninsured and indigent in 2009 and PHS' founder, Dr. [read post]
27 Apr 2010, 10:58 pm
(Patent Docs) Prilosec (Omeprazole) – US: Dr Reddy’s wins attorney’s fees from AstraZeneca in Prilosec OTC case (Orange Book Blog) Protonix (Pantoprazole) – US: Jury finds Protonix patent infringed by Teva (The IP Factor) Restasis (Ciclosporin) – Restasis royalty dispute finally settles (IP finance) Tarceva (Erlotinib) – India: Roche and Tarceva in Delhi HC again, this time vs Natco (Spicy IP) (Generic Pharmaceuticals and IP) Viagra (Sildenafil)… [read post]
25 Apr 2010, 9:10 pm by Aaron Barkoff
Reddy's, No. 07–6790 (S.D.N.Y. 2010) by Jim Wasicak and Aaron Barkoff After Dr. [read post]